Biotech Research Deals: $2 Mil. Per Year Per Deal Is Limit - P&U's Ando
Executive Summary
Pharmaceutical manufacturers are wary of spending more than $2 mil. per year on any individual research collaboration with a biotech firm, Pharmacia & Upjohn Exec VP-R&D Goran Ando suggested at an Ernst & Young/Atlas Venture life sciences conference in Amsterdam April 27.